Location: | London |
---|---|
Salary: | £38,483 to £45,974 per annum |
Hours: | Full Time |
Contract Type: | Fixed-Term/Contract |
Placed On: | 22nd April 2025 |
---|---|
Closes: | 20th May 2025 |
Job Ref: | 5679 |
About the Role
We seek a Postdoctoral Research Associate to join the Translational Lymphoma Research group of Professor Okosun. Our lab studies the pathogenesis of lymphomas, investigating intra-tumour heterogeneity, clonal evolution, biomarkers of response and resistance to therapies and developing methodologies to study lymphoma cell populations (Okosun et al, 2014; 2016, Nature Genetics; Araf et al, Leukemia 2018; Poynton et al, Blood Adv 2023; Coulter et al, J Mol Diagn 2024). The wet lab/computational biology postdoc will lead a project investigating residual follicular lymphoma cell populations using patient samples and employing a combination of multi-modal techniques (scRNA-seq, scATAC-seq, ResolveOME) to develop novel assays for disease monitoring. The post is based at the Barts Cancer Institute (BCI) in London, with an ideal start date of July 2025.
About You
The successful candidate will be highly-motivated, have a PhD (or close to completion)* in a biological or computational discipline, with strong expertise in experimental multi-omics techniques and computational biology alongside experience with flow cytometry and bulk/single cell bioinformatics in genomics/transcriptomics.
About the Institute
The BCI is a Cancer Research UK Centre of Excellence whose work aims to transform the lives of those with and at risk of cancer through innovative research in the laboratory, in patients and in populations. It is one of six institutes within The Faculty of Medicine and Dentistry. BCI is internationally renowned in many areas of cancer research and it combines ground-breaking basic research with the expertise of clinicians and clinician scientists from the Centre for Experimental Cancer Medicine and the Barts NHS Trust to achieve improvements in cancer patient care. BCI is a partner in the CRUK City of London Major Centre (together with UCL, Kings and the Francis Crick Institute) which is a Centre of Excellence in Biotherapeutics. We are committed in supporting and developing future cancer researchers through its extensive postgraduate training.
About Queen Mary
At Queen Mary University of London, we believe that a diversity of ideas helps us achieve the previously unthinkable.
Throughout our history, we’ve fostered social justice and improved lives through academic excellence. And we continue to live and breathe this spirit today, not because it’s simply ‘the right thing to do’ but for what it helps us achieve and the intellectual brilliance it delivers.
We continue to embrace diversity of thought and opinion in everything we do, in the belief that when views collide, disciplines interact, and perspectives intersect, truly original thought takes form.
Benefits
We offer competitive salaries, access to a generous pension scheme, 30 days’ leave per annum (pro-rata for part-time/fixed-term), a season ticket loan scheme and access to a comprehensive range of personal and professional development opportunities. In addition, we offer a range of work life balance and family friendly, inclusive employment policies, flexible working arrangements, and campus facilities.
Queen Mary’s commitment to our diverse and inclusive community is embedded in our appointments processes. Reasonable adjustments will be made at each stage of the recruitment process for any candidate with a disability. We are open to considering applications from candidates wishing to work flexibly.
*PhD candidates who are close to completion and have not yet received their PhD award, will be appointed on a salary of £38,483. On providing a copy of the formal award letter or award certificate, the salary will increase to £41,510.
Closing Date: 20/05/2025, 23:55
Type / Role:
Subject Area(s):
Location(s):